Molgramostim biosimilar (BioGeneric Pharma)

莫拉司亭生物类似药 (BioGeneric Pharma)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMolgramostim biosimilar (BioGeneric Pharma)

Drug Alias NameRecombinant human granulocyte-macrophage colony stimulating factor (BioGeneric Pharma)莫拉司亭生物仿制药 (BioGeneric Pharma)rHuGM-CSF (BioGeneric Pharma)Molgramostim follow-on biologic (BioGeneric Pharma)

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulants

TargetsGranulocyte-macrophage colony-stimulating factor receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesBiogeneric Pharma

China Registration ClassN/A

Develop Information

Active CompaniesBiogeneric Pharma

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA03